Skip to main content
Article thumbnail
Location of Repository

Genetic polymorphisms of angiotensin-2 type 1 receptor and angiotensinogen and risk of renal dysfunction and coronary heart disease in type 2 diabetes mellitus

By Julie Lin, Frank B Hu, Lu Qi and Gary C Curhan
Topics: Research Article
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2002). [Association of the renin-angiotensin system gene polymorphism with nephropathy in type II diabetes]. Pol Arch Med Wewn
  2. (1997). A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro.
  3. (2003). A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study.
  4. (2005). Ageing and plasma adiponectin concentration in apparently healthy males and females. Clin Endocrinol (Oxf)
  5. (1996). Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy.
  6. (1999). Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease.
  7. (2003). Angiotensinogen single nucleotide polymorphisms, elevated blood pressure, and risk of cardiovascular disease. Hypertension
  8. (2001). Association of angiotensinogen M235T and A(-6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: the PROCAGENE study. Prospective Cardiac Gene.
  9. (2006). Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms.
  10. (1983). Cigarette smoking, relative weight, and menopause.
  11. (1998). Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans.
  12. (1998). Diabetic nephropathy is associated with AGT polymorphism T235: results of a family-based study. Hypertension
  13. (2005). Dietary pattern, inflammation, and incidence of type 2 diabetes in women.
  14. (2001). Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.
  15. (2000). Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet
  16. (1996). Elevated plasma levels of vascular cell adhesion molecule-1 (VCAM-1) in diabetic patients with microalbuminuria: a marker of vascular dysfunction and progressive vascular disease.
  17. (2001). et al.: Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease. Kidney International
  18. (1997). et al.: Genetic variants of the renin-angiotensin system, diabetic nephropathy and hypertension. Diabetologia
  19. (2006). et al.: Influence of gender and genetic variability on plasma angiotensin peptides. J Renin Angiotensin Aldosterone Syst
  20. (1999). et al.: M235T angiotensinogen gene polymorphism and cardiovascular renal risk.
  21. (1998). et al.: Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia
  22. (2005). Folate intake and the risk of incident hypertension among US women. Jama
  23. (1976). Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron
  24. (2006). Gender differences in the renal response to renin-angiotensin system blockade.
  25. (2006). Genetic variation of the renin-angiotensin system and chronic kidney disease progression in black individuals in the atherosclerosis risk in communities study.
  26. (2001). Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States.
  27. (1997). Ichikawa I: Biological functions of angiotensin and its receptors. Annual Review of Physiology
  28. (1999). Lack of association of angiotensin-converting enzyme (DD/II) and angiotensinogen M235T gene polymorphism with renal function among Chinese patients with type II diabetes.
  29. (2003). Physical activity in relation to cardiovascular disease and total mortality among men with type 2 diabetes. Circulation
  30. (1999). Polymorphisms of angiotensin-converting enzyme and angiotensinogen genes in type 2 diabetic sibships in relation to albumin excretion rate.
  31. (2002). Recommendations for healthcare system and self-management education interventions to reduce morbidity and mortality from diabetes.
  32. (2004). Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. Diabetes Care
  33. (2002). Relationship between polymorphisms in the renin-angiotensin system and nephropathy in type 2 diabetic patients. Diabetes Metab
  34. (2003). Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease. Kardiol Pol
  35. (1999). Scholey JW: Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II[see comment]. Kidney International
  36. (1996). Tomono S: Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics. Metabolism

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.